Salivary Proteomics Profiling Reveals Potential Biomarkers for Chronic Kidney Disease: a Pilot Study

Overview

Journal Front Med (Lausanne)

Date 2025 Feb 3

PMID 39895822

Authors

Bianca Uliana Picolo

Nathalia Rabello Silva

Mario Machado Martins

Hebreia Oliveira Almeida-Souza

Leticia Cristina Machado de Sousa

Richard Costa Polveiro

Luiz Ricardo Goulart Filho

Robinson Sabino-Silva

Vivian Alonso-Goulart

Luciana Saraiva da Silva

Affiliations

Soon will be listed here.

Abstract

Introduction: Chronic kidney disease (CKD) is a global public health problem, and the absence of reliable and accurate diagnostic and monitoring tools contributes to delayed treatment, impacting patients' quality of life and increasing treatment costs in public health. Proteomics using saliva is a key strategy for identifying potential disease biomarkers.

Methods: We analyzed the untargeted proteomic profiles of saliva samples from 20 individuals with end-stage kidney disease (ESKD) ( = 10) and healthy individuals ( = 10) using liquid chromatography-tandem mass spectrometry (LC-MS/MS) to identify potential biomarkers for CKD. A volcano plot was generated using a -value of ≤0.05 and a fold change (FC) ≥ 2.0. Multivariate analysis was performed to generate the orthogonal partial least squares discriminant analysis (OPLS-DA) model and the variable importance in projection (VIP) scores. The accuracy of candidate biomarker proteins was evaluated using receiver operating characteristic (ROC) curves.

Results: In total, 431 proteins were identified in the salivary proteomic profile, and 3 proteins were significantly different between the groups: apoptosis inhibitor 5 (API5), phosphoinositide phospholipase C (PI-PLC), and small G protein signaling modulator 2 (Sgsm2). These proteins showed good accuracy based on the ROC curve and a VIP score of >2.0. During pathway enrichment, PI-PLC participates in the synthesis of IP3 and IP4 in the cytosol. Gene ontology (GO) analysis revealed data on molecular functions, biological processes, cellular components, and protein classes.

Conclusion: We can conclude that the salivary API5, PI-PLC, and Sgsm2 can be potential biomarker candidates for CKD detection. These proteins may participate in pathways related to renal fibrosis and other associated diseases, such as mineral and bone disorders.

References

Matsushita K, Ballew S, Yee-Moon Wang A, Kalyesubula R, Schaeffner E, Agarwal R . Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease. Nat Rev Nephrol. 2022; 18(11):696-707. DOI: 10.1038/s41581-022-00616-6. View

Fan G, Gong T, Lin Y, Wang J, Sun L, Wei H . Urine proteomics identifies biomarkers for diabetic kidney disease at different stages. Clin Proteomics. 2021; 18(1):32. PMC: 8903606. DOI: 10.1186/s12014-021-09338-6. View

Kovesdy C . Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl (2011). 2022; 12(1):7-11. PMC: 9073222. DOI: 10.1016/j.kisu.2021.11.003. View

Rao P, Reddy A, Lu X, Dasari S, Krishnaprasad A, Biggs E . Proteomic identification of salivary biomarkers of type-2 diabetes. J Proteome Res. 2009; 8(1):239-45. DOI: 10.1021/pr8003776. View

Yang H, Sasaki T, Minoshima S, Shimizu N . Identification of three novel proteins (SGSM1, 2, 3) which modulate small G protein (RAP and RAB)-mediated signaling pathway. Genomics. 2007; 90(2):249-60. DOI: 10.1016/j.ygeno.2007.03.013. View

Zoccali C, Mallamaci F . Innate Immunity System in Patients With Cardiovascular and Kidney Disease. Circ Res. 2023; 132(8):915-932. DOI: 10.1161/CIRCRESAHA.122.321749. View

Aslam B, Basit M, Nisar M, Khurshid M, Rasool M . Proteomics: Technologies and Their Applications. J Chromatogr Sci. 2017; 55(2):182-196. DOI: 10.1093/chromsci/bmw167. View

Cheng S, Jiang Y, Kuo H . Urothelial Dysfunction and Chronic Inflammation are Associated With Increased Bladder Sensation in Patients With Chronic Renal Insufficiency. Int Neurourol J. 2018; 22(Suppl 1):S46-54. PMC: 5798634. DOI: 10.5213/inj.1832814.407. View

Wai-Hoe L, Wing-Seng L, Ismail Z, Lay-Harn G . Proteomics and detection of uromodulin in first-time renal calculi patients and recurrent renal calculi patients. Appl Biochem Biotechnol. 2009; 159(1):221-32. DOI: 10.1007/s12010-008-8503-x. View

10.

Mihai S, Codrici E, Popescu I, Enciu A, Rusu E, Zilisteanu D . Proteomic Biomarkers Panel: New Insights in Chronic Kidney Disease. Dis Markers. 2016; 2016:3185232. PMC: 5030443. DOI: 10.1155/2016/3185232. View

11.

Loo J, Yan W, Ramachandran P, Wong D . Comparative human salivary and plasma proteomes. J Dent Res. 2010; 89(10):1016-23. PMC: 3144065. DOI: 10.1177/0022034510380414. View

12.

Huang Q, Fei X, Zhong Z, Zhou J, Gong J, Chen Y . Stratification of diabetic kidney diseases data-independent acquisition proteomics-based analysis of human kidney tissue specimens. Front Endocrinol (Lausanne). 2022; 13:995362. PMC: 9714485. DOI: 10.3389/fendo.2022.995362. View

13.

Harlacher E, Wollenhaupt J, Baaten C, Noels H . Impact of Uremic Toxins on Endothelial Dysfunction in Chronic Kidney Disease: A Systematic Review. Int J Mol Sci. 2022; 23(1). PMC: 8745705. DOI: 10.3390/ijms23010531. View

14.

Gajjala P, Bruck H, Noels H, Heinze G, Ceccarelli F, Kribben A . Novel plasma peptide markers involved in the pathology of CKD identified using mass spectrometric approach. J Mol Med (Berl). 2019; 97(10):1451-1463. PMC: 6746684. DOI: 10.1007/s00109-019-01823-8. View

15.

Wu Z, Wang J, Zhang X . Diagnostic model of saliva protein finger print analysis of patients with gastric cancer. World J Gastroenterol. 2009; 15(7):865-70. PMC: 2653388. DOI: 10.3748/wjg.15.865. View

16.

Berridge M . The Inositol Trisphosphate/Calcium Signaling Pathway in Health and Disease. Physiol Rev. 2016; 96(4):1261-96. DOI: 10.1152/physrev.00006.2016. View

17.

Fragiadaki M, Mason R . Epithelial-mesenchymal transition in renal fibrosis - evidence for and against. Int J Exp Pathol. 2011; 92(3):143-50. PMC: 3101487. DOI: 10.1111/j.1365-2613.2011.00775.x. View

18.

Provenzano M, Serra R, Garofalo C, Michael A, Crugliano G, Battaglia Y . OMICS in Chronic Kidney Disease: Focus on Prognosis and Prediction. Int J Mol Sci. 2022; 23(1). PMC: 8745343. DOI: 10.3390/ijms23010336. View

19.

Jung J, Nam J, Ryu K, Son I, Shin J, Baek W . Salivary Immunoglobulin Gamma-3 Chain C Is a Promising Noninvasive Biomarker for Systemic Lupus Erythematosus. Int J Mol Sci. 2021; 22(3). PMC: 7866502. DOI: 10.3390/ijms22031374. View

20.

Hruska K, Sugatani T, Agapova O, Fang Y . The chronic kidney disease - Mineral bone disorder (CKD-MBD): Advances in pathophysiology. Bone. 2017; 100:80-86. PMC: 5502716. DOI: 10.1016/j.bone.2017.01.023. View